Overview
Pulmonary eosinophilia refers to an elevated number of eosinophils in the lungs, often indicative of underlying inflammatory or parasitic conditions. It can result from various causes including parasitic infections, drug reactions, and specific syndromes like hypereosinophilic disorders 35.Diagnosis
Clinical Context: Consider travel history, exposure to allergens, and recent medication use 35.
Laboratory Tests: Elevated peripheral blood eosinophil count 14.
Imaging: Chest imaging may reveal infiltrates or other pulmonary abnormalities 1.
Specific Tests:
- Parasite Screening: Stool and sputum examinations for helminths 3.
- Allergy Testing: To rule out allergic causes 3.
- Drug Allergy Testing: Particularly relevant if recent drug exposure 5.
Bone Marrow Examination: In cases of persistent or severe eosinophilia to assess maturation stages 4.Management
First-Line Treatments:
- Identify and Remove Cause: Address underlying triggers such as parasites, allergens, or medications 35.
- Antihistamines: For symptomatic relief in allergic causes 3.
Adjunctive Treatments:
- Corticosteroids: For inflammatory conditions 1.
- Eosinophil-Targeted Therapy: Specific drugs like mepolizumab in refractory cases 1.Special Populations
Pediatrics: Increased eosinophils can indicate transient conditions or malignancies; bone marrow analysis crucial 4.
Drug-Induced Eosinophilia: Recognize carbamazepine as a potential trigger requiring careful monitoring and challenge testing 5.Key Recommendations
Initiate a Comprehensive Workup for unexplained eosinophilia, including travel history, parasite screening, and allergy testing (Evidence: Moderate 3).
Targeted Therapy Based on Underlying Cause: Address specific triggers like parasites or drug reactions (Evidence: Moderate 35).
Consider Bone Marrow Examination in pediatric patients or when peripheral eosinophilia is persistent and severe (Evidence: Weak 4).
Monitor and Manage Drug-Induced Eosinophilia by identifying and discontinuing offending agents (Evidence: Expert opinion 5).References
1 Groh M, Rohmer J, Etienne N, Abou Chahla W, Baudet A, Chan Hew Wai A et al.. French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes. Orphanet journal of rare diseases 2023. link
2 Kay AB. Was Thomas Wharton Jones FRS, assistant to the infamous Dr Knox, the first to recognise the blood eosinophil?. The journal of the Royal College of Physicians of Edinburgh 2019. link
3 Wolfe MS. Eosinophilia in the returning traveler. Infectious disease clinics of North America 1992. link
4 Ishii E, Mizuno Y, Hara T, Okamura J, Aoki T, Kanehara Y et al.. Eosinophilia in children. Cytochemical and immunological analysis of increased eosinophils. The American journal of pediatric hematology/oncology 1987. link
5 Tolmie J, Steer CR, Edmunds AT. Pulmonary eosinophilia associated with carbamazepine. Archives of disease in childhood 1983. link
6 Donohugh DL. Eosinophils and eosinophilia. California medicine 1966. link